GE HealthCare Technologies GEHC Product — Remaining performance obligations, amount

Other product segments

Similar metrics at other companies

CSCOProduct — Remaining performance obligation

$22.06B+6.3%

ANETProduct — Revenue, remaining performance obligation, amount

$1.2B+186%

FCELProduct — Revenue Remaining Performance Obligation

$36.1M-63.2%

ORAProduct — Revenue, remaining performance obligation, amount

$203.2M-35.3%

PLUGOther Product And Services — Revenue Remaining Performance Obligation

$646K—

ANIPSales of contract manufactured products — Remaining performance obligations

$3.2M—

Questions, answered.

What is GE HealthCare Technologies's product — remaining performance obligations, amount?

GE HealthCare Technologies (GEHC) reported product — remaining performance obligations, amount of $5.14B in Q1 2026.

How has GE HealthCare Technologies's product — remaining performance obligations, amount changed year-over-year?

GE HealthCare Technologies's product — remaining performance obligations, amount increased by 11.8% year-over-year, from $4.6B to $5.14B.

What is the long-term trend for GE HealthCare Technologies's product — remaining performance obligations, amount?

Over 2 years (2023 to 2025), GE HealthCare Technologies's product — remaining performance obligations, amount has grown at a -1.1% compound annual growth rate (CAGR), from $19.75B to $19.3B.

What does product — remaining performance obligations, amount mean?

Represents the total transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. This provides visibility into the backlog of product orders that have been booked but not yet recognized as revenue.